Longyang N. Liu

Guangzhou, 510000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Expression and clinical value of EIF3CL in serous ovarian cancer.

Expression and clinical value of EIF3CL in serous ovarian cancer.

Journal: The Journal of international medical research

Published: May 26, 2025

MYH9 Promotes the Proliferation and Progression of Squamous Cervical Cancer Cells.

MYH9 Promotes the Proliferation and Progression of Squamous Cervical Cancer Cells.

Journal: Recent patents on anti-cancer drug discovery

Published: April 10, 2025

Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma.

Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma.

Journal: Cancer cell international

Published: December 18, 2022

Circ_0070203 Promotes Epithelial-mesenchymal Transition in Ovarian Serous Cystadenocarcinoma through miR-370-3p/TGFβR2 Axis.

Circ_0070203 Promotes Epithelial-mesenchymal Transition in Ovarian Serous Cystadenocarcinoma through miR-370-3p/TGFβR2 Axis.

Journal: Recent patents on anti-cancer drug discovery

Published: November 22, 2022

MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance.

MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 12, 2022

Impedance matching system using triple liquid stub tuners for high-power ion cyclotron resonance heating in EAST tokamak.

Impedance matching system using triple liquid stub tuners for high-power ion cyclotron resonance heating in EAST tokamak.

Journal: The Review of scientific instruments

Published: April 30, 2022

Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer.

Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer.

Journal: Frontiers in molecular biosciences

Published: September 29, 2021

NAP1L1 promotes proliferation and chemoresistance in glioma by inducing CCND1/CDK4/CDK6 expression through its interaction with HDGF and activation of c-Jun.

NAP1L1 promotes proliferation and chemoresistance in glioma by inducing CCND1/CDK4/CDK6 expression through its interaction with HDGF and activation of c-Jun.

Journal: Aging

Published: September 07, 2021

VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.

VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.

Journal: Cancer science

Published: December 29, 2020

Expression and Clinical Significance of Microtubule-Actin Cross-Linking Factor 1 in Serous Ovarian Cancer.

Expression and Clinical Significance of Microtubule-Actin Cross-Linking Factor 1 in Serous Ovarian Cancer.

Journal: Recent patents on anti-cancer drug discovery

Published: September 08, 2020

High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer.

High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer.

Journal: Recent patents on anti-cancer drug discovery

Published: September 03, 2020

FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancer.

FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancer.

Journal: Cancer biomarkers : section A of Disease markers

Published: April 01, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026